Friday, February 26, 2021

Canadian study says oral medicine effective in treating Covid-19

The study results show that colchicine reduced by 21% the risk of death or hospitalisations in patients with Covid-19 compared to placebo.

Other News

Ismail Sabri terima suntikan vaksin Covid-19

Turut menerima suntikan hari ini ialah timbalan menteri pertahanan, ketua setiausaha, panglima angkatan tentera dan panglima-panglima perkhidmatan.

Art Harun terkejut dengan sikap rakan-rakan selepas dilantik speaker

Bekas peguam itu menceritakan hal peribadinya termasuk bagaimana proses pelantikannya sebagai speaker Dewan Rakyat dijadikan isu peribadi.

Speaker Art Harun shocked by friends who ‘unfriended’ him

The former lawyer opens up about himself, including how his appointment as Dewan Rakyat speaker has taken a personal toll.

Cocaine worth billions seized in Europe’s biggest ever smuggling bust

Authorities are saying so far the record breaking haul has led to the arrest of just one man, 'whose address was on the shipment'.

Dubai’s captive princess urges UK cops to reopen disappeared sister’s kidnap case

Diplomatic 'sensitivities' mean the police are experiencing difficulties making any further progress.

A major clinical trial shows that an inflammatory drug called colchicine is effective in treating Covid-19 and reduces the risk of complications from the disease, doctors in Canada said.

The results of the study are a “major scientific discovery” and make colchicine – a medicine used to treat gout – “the world’s first oral drug that could be used to treat non-hospitalised patients with Covid-19”, the Montreal Heart Institute said in a statement late Friday.

The study results show that colchicine reduced by 21% the risk of death or hospitalisations in patients with Covid-19 compared to placebo, the institute said.

The study was carried out in Canada, the US, Europe and South America among a population of 4,488 patients.

In 4,159 of these patients, in whom the diagnosis of Covid-19 was proven by a naso-pharyngeal PCR test, use of colchicine reduced hospitalisations by 25%, the need for mechanical ventilation by 50%, and deaths by 44%, the study concluded.

Colchicine is effective in preventing dangerous inflammatory syndromes called “cytokine storms” and reducing complications associated with Covid-19, said Dr Jean-Claude Tardif, director of the MHI Research Center and principal investigator in this study.

“We are pleased to offer the first oral medication in the world whose use could have a significant impact on public health and potentially prevent Covid-19 complications for millions of patients,” Tardif said.

The study was conducted among Covid-19 patients not hospitalised at the time of enrollment in the trial, and with at least one risk factor for Covid-19 complications.

“This is the world’s largest study testing an orally administered drug in non-hospitalized patients with Covid-19,” the heart institute said.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Maximum RM10,000 fine for SOP offenders beginning March 11

Companies or corporations that violate the SOPs can be fined up to RM50,000.

China approves 2 more home-grown Covid-19 vaccines for use

China is exporting vaccines to 27 countries and providing free doses to 53 others, a foreign ministry spokesman says.

US approves Pfizer vaccine storage at normal freezer temperature

The move loosens a previous requirement that the vaccine should be stored at ultra-low temperatures, between -80 to -60 degrees Celsius.

It’s not just about patent rights, expert says on ways to make Covid jabs cheaper

India's Serum Institute offers a good example of overcoming the problem of vaccine exclusivity during the current health emergency.

New cases drop below 2,000 mark

12 more deaths reported.